Raffa Wealth Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$463 Hold
2
– – ﹤0.01% 1205
2026
Q2
$482 Buy
2
+1
+100% +$219 ﹤0.01% 1189
2026
Q1
$189 Buy
+1
New +$175 ﹤0.01% 1188
2016
Q4
– Sell
-10
Closed -$1.22K – 889
2016
Q3
$1.22K Hold
10
– – ﹤0.01% 364
2016
Q2
$1.41K Buy
10
+1
+11% +$147 ﹤0.01% 316
2016
Q1
$1.18K Hold
9
– – ﹤0.01% 358
2015
Q4
$1.26K Hold
9
– – ﹤0.01% 340
2015
Q3
$1.2K Hold
9
– – ﹤0.01% 347
2015
Q2
$1.58K Hold
9
– – ﹤0.01% 305
2015
Q1
$1.56K Buy
+9
New +$1.54K ﹤0.01% 297

Other funds holding JAZZ

Raffa Wealth Management's JAZZ Position: Q3 2026 in Review

Raffa Wealth Management held its Jazz Pharmaceuticals (JAZZ) position steady in Q3 2026 at 2 shares worth $463. The position accounts for ﹤0.01% of the portfolio, ranked #1205.

Raffa Wealth Management first reported a position in JAZZ in Q1 2015 and has held it in 10 quarters since. The position peaked at $1.58K in Q2 2015. 669 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.

  • Raffa Wealth Management held 2 shares of Jazz Pharmaceuticals worth $463 as of Q3 2026.
  • Raffa Wealth Management left its Jazz Pharmaceuticals share count unchanged in Q3 2026.
  • Jazz Pharmaceuticals made up ﹤0.01% of Raffa Wealth Management's portfolio in Q3 2026, its #1205 holding.
  • Raffa Wealth Management first reported a position in Jazz Pharmaceuticals in Q1 2015 and has held it in 10 quarters since.
  • Raffa Wealth Management's Jazz Pharmaceuticals position peaked at $1.58K in Q2 2015.
  • 669 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.

Based on Raffa Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.